The future of medicine will be creating partnerships with other providers and other healthcare organizations that are like-minded and looking to enter into value-based modes of care to create networks taht aren't narrow but are coordinated and high performing, said Farzad Mostashari, MD, former National Coordinator of Health Information Technology and co-founder and chief executive officer of Aledade.
The future of medicine will be creating partnerships with other providers and other healthcare organizations that are like-minded and looking to enter into value-based modes of care to create networks taht aren't narrow but are coordinated and high performing, said Farzad Mostashari, MD, former National Coordinator of Health Information Technology and co-founder and chief executive officer of Aledade.
Transcript (slightly modified)
What is the importance of teamwork and collaboration for ACOs, accountable care in general, and population health?
Healthcare is a team sport. The average Medicare patient might have 7 difference doctors that they see, and particularly when people get sick, they are bouncing around between acute care, and post-acute care, and emergency departments, urgent care, and imaging, and all this mess without anyone actually being accountable or in charge of the patient's care. So teamwork becomes really essential, but I think the key component of that teamwork is to have a quarterback for the patient to know who's watching out for them, who's coordinating their care. And I believe that is primary care.
That is the appropriate role for primary care and primary care physicians being at the top of their practices and having a team around them to support them so that some of the more routine work gets done by some of their staff, so they can be focused on the sickest patients who have the most demanding challenges.
But that's all within the practice, right? We talk about patient-centered medical home or team-based care. That's within the box and accountable care says, "No, your accountability and your ability to work as teams has to go outside the box to all the different people." And primary care right now doesn't even have visibility into where their patients are going and what is all the care that they're receiving. So that's the opportunity and the challenge when we're talking about teams and collaboration: are there people outside that share your incentives and have shared in your decision to enter into value-based modes of caring, as opposed to churning fee-for-service.
Finding those partners, finding those collaborators in the care of the patient, and constructing networks of care that are not narrow, they're actually coordinated, they're actually high-performing networks: that is the future.
Sequencing CAR T and Bispecifics for Multiple Myeloma: Tyler Sandahl, PharmD
July 8th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients, while bispecific antibodies are reserved for later lines or for patients unable to tolerate CAR T.
Read More
Driving Value via Outcomes-Based Pricing and EHR Interoperability: Tyler Sandahl, PharmD
July 7th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, discussed the complexities of alternative payment models for chimeric antigen receptor T-cell and bispecific therapies and the need for improved data sharing in cancer care.
Read More
Targeting the Root of gMG With Inebilizumab: A Q&A With Richard Nowak, MD, MS
June 24th 2025In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant improvements in patient- and physician-assessed outcomes, as well as longer-term implications and future areas of investigation.
Read More